Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Good
|
|
New words:
accredited, Allergy, asset, Biogen, Biology, bioterrorism, Calando, coupon, de, director, diversity, Ebola, EMBL, EMBLEM, Enterprise, fatal, fever, Foerdung, hemorrhagic, hierarchy, Idec, indefinite, Inex, instructed, issuer, largest, leukoencephalopathy, licensee, longest, main, MaxPlanck, MIT, Molecular, multifocal, NDA, NIAID, NIH, opportunity, optimize, PML, principle, progressive, purification, quantification, quantify, Quantifying, Quark, resell, shift, slight, spectrum, straight, subsidiary, thereunder, threat, timeline, vur, WI
Removed:
degeneration, macular, newly, prime, Pulmozyme, realized, TOBI, treating
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 EX-10.1 Collaboration and License Agreement by and Between the Registrant and Biogen Idec Ma. Inc. Dated September 20, 2006
- 10.2 EX-10.2 Letter Agreement by and Between the Registrant and Vincent J. Miles Effective As of October 20, 2006
- 31.1 EX-31.1 Section 302 Certification of CEO
- 31.2 EX-31.2 Section 302 Certification of CFO
- 32.1 EX-32.1 Section 906 Certification of CEO
- 32.2 EX-32.2 Section 906 Certification of CFO
Related press release
ALNY similar filings
External links